About this Journal Submit a Manuscript Table of Contents

Citations to this Journal [343 citations: 1–100 of 310 articles]

Articles published in Schizophrenia Research and Treatment have been cited 343 times. The following is a list of the 310 articles that have cited the articles published in Schizophrenia Research and Treatment.

  • M. Möller, T. Swanepoel, and B. H. Harvey, “Neurodevelopmental Animal Models Reveal the Convergent Role of Neurotransmitter Systems, Inflammation, and Oxidative Stress as Biomarkers of Schizophrenia: Implications for Novel Drug Development,” ACS Chemical Neuroscience, pp. 150402134223006, 2015. View at Publisher · View at Google Scholar
  • A. L. Sutterland, G. Fond, A. Kuin, M. W. J. Koeter, R. Lutter, T. van Gool, R. Yolken, A. Szoke, M. Leboyer, and L. de Haan, “ Beyond the association. Toxoplasma gondii in schizophrenia, bipolar disorder, and addiction: systematic review and meta-analysis ,” Acta Psychiatrica Scandinavica, 2015. View at Publisher · View at Google Scholar
  • M. De Hert, J. Peuskens, T. Sabbe, A. J. Mitchell, B. Stubbs, P. Neven, H. Wildiers, and J. Detraux, “Relationship between prolactin, breast cancer risk, and antipsychotics in patients with schizophrenia: a critical review,” Acta Psychiatrica Scandinavica, 2015. View at Publisher · View at Google Scholar
  • Menka Tsantefski, Alun C. Jackson, and Cathy Humphreys, “A delicate balance: intervention with mothers with dual diagnosis and their infants,” Advances in Dual Diagnosis, vol. 8, no. 2, pp. 78–89, 2015. View at Publisher · View at Google Scholar
  • Ian Hamilton, Paul Galdas, and Holly Essex, “Cannabis psychosis, gender matters,” Advances in Dual Diagnosis, vol. 8, no. 3, pp. 153–162, 2015. View at Publisher · View at Google Scholar
  • Sadao Otsuka, Mie Matsui, Takatoshi Hoshino, Kayoko Miura, Yuko Higuchi, and Michio Suzuki, “The Effectiveness and Applicability of Compensatory Cognitive Training for Japanese Patients with Schizophrenia: A Pilot Study,” Advances in Psychiatry, vol. 2015, pp. 1–12, 2015. View at Publisher · View at Google Scholar
  • Marcelo Valencia, Juan A. Moriana, Alex Kopelowicz, Steven R. Lopez, and Robert P. Liberman, “Social-Skills Training for Spanish-Speaking Persons with Schizophrenia: Experiences From Latin America, Spain, and the United States,” American Journal of Psychiatric Rehabilitation, vol. 18, no. 3, pp. 209–246, 2015. View at Publisher · View at Google Scholar
  • Anne Gut-Fayand, “Éducation thérapeutique du patient et schizophrénies débutantes,” Annales Médico-psychologiques, revue psychiatrique, 2015. View at Publisher · View at Google Scholar
  • Federica Pinna, Luca Deriu, Enrica Diana, Valeria Perra, Rachele Pisu Randaccio, Lucia Sanna, Massimo Tusconi, and Bernardo Carpiniello, “Clinical Global Impression-severity score as a reliable measure for routine evaluation of remission in schizophrenia and schizoaffective disorders,” Annals of General Psychiatry, vol. 14, no. 1, 2015. View at Publisher · View at Google Scholar
  • Kiran Jakhar, Triptish Bhatia, Rahul Saha, and Smita Deshpande, “A Cross Sectional Study of Prevalence and Correlates of Current and Past Risks in Schizophrenia,” Asian Journal of Psychiatry, 2015. View at Publisher · View at Google Scholar
  • Jayashri Kulkarni, and Kate Reeve-Parker, “Psychiatrists' awareness of partial- and non-adherence to antipsychotic medication in schizophrenia: results from the Australian ADHES survey,” Australasian Psychiatry, vol. 23, no. 3, pp. 258–264, 2015. View at Publisher · View at Google Scholar
  • Antonio Vita, Luca De Peri, Giacomo Deste, Stefano Barlati, and Emilio Sacchetti, “The Effect of Antipsychotic Treatment on Cortical Gray Matter Changes in Schizophrenia: Does the Class Matter? A Meta-analysis and Meta-regression of Longitudinal Magnetic Resonance Imaging Studies,” Biological Psychiatry, 2015. View at Publisher · View at Google Scholar
  • Christina Daniel, and Oliver J. Mason, “Predicting Psychotic-Like Experiences during Sensory Deprivation,” BioMed Research International, vol. 2015, pp. 1–10, 2015. View at Publisher · View at Google Scholar
  • Christina Daniel, and Oliver J. Mason, “Predicting Psychotic-Like Experiences during Sensory Deprivation,” Biomed Research International, 2015. View at Publisher · View at Google Scholar
  • Annika Rose, Sophia Vinogradov, Melissa Fisher, Michael F. Green, Joseph Ventura, Christine Hooker, Michael Merzenich, and Mor Nahum, “Randomized controlled trial of computer-based treatment of social cognition in schizophrenia: the TRuSST trial protocol,” Bmc Psychiatry, vol. 15, 2015. View at Publisher · View at Google Scholar
  • Zhi Zhang, and Henriette van Praag, “Maternal immune activation differentially impacts mature and adult-born hippocampal neurons in male mice,” Brain, Behavior, and Immunity, vol. 45, pp. 60–70, 2015. View at Publisher · View at Google Scholar
  • Marjolaine Masson, Til Wykes, Michel Maziade, Clare Reeder, Marie-Anne Gariépy, Marc-André Roy, Hans Ivers, and Caroline Cellard, “Top-Down Computerized Cognitive Remediation in Schizophrenia: A Case Study of an Individual with Impairment in Verbal Fluency,” Case Reports in Psychiatry, vol. 2015, pp. 1–10, 2015. View at Publisher · View at Google Scholar
  • Jancy Jose, H. Nandeesha, Shivanand Kattimani, Kavitha Meiyappan, Siddharth Sarkar, and Devanarayanan S, “Association between prolactin and thyroid hormones with severity of psychopathology and suicide risk in drug free male schizophrenia,” Clinica Chimica Acta, 2015. View at Publisher · View at Google Scholar
  • lement Zai Ali Bani Fatemi C, and Vincenzo De Luca, “Early Onset Schizophrenia: Gender Analysis of Genome-Wide Potential Methylation,” Clinica Chimica Acta, 2015. View at Publisher · View at Google Scholar
  • Marc De Hert, Jan Sermon, Paul Geerts, Kristof Vansteelandt, Joseph Peuskens, and Johan Detraux, “The Use of Continuous Treatment Versus Placebo or Intermittent Treatment Strategies in Stabilized Patients with Schizophrenia: A Systematic Review and Meta-Analysis of Randomized Controlled Trials with First- and Second-Generation Antipsychotics,” CNS Drugs, 2015. View at Publisher · View at Google Scholar
  • Steffen Moritz, Helena Mayer-Stassfurth, Lisa Endlich, Christina Andreou, Nora Ramdani, Franz Petermann, and Ryan P. Balzan, “The Benefits of Doubt: Cognitive Bias Correction Reduces Hasty Decision-Making in Schizophrenia,” Cognitive Therapy and Research, 2015. View at Publisher · View at Google Scholar
  • Mercedes Hernandez, and Concepción Barrio, “Perceptions of Subjective Burden Among Latino Families Caring for a Loved One with Schizophrenia,” Community Mental Health Journal, 2015. View at Publisher · View at Google Scholar
  • Susana Ochoa, Francisco Martínez-Zambrano, Mar Garcia-Franco, Sonia Vilamala, Maria Ribas, Oti Arenas, Esther Garcia-Morales, Irene Álvarez, Gemma Escartin, Raul Villellas, Maria Jose Escandell, Mónica Martínez-Raves, Elisabeth López-Arias, Christian Cunyat, and Josep Maria Haro, “Development and validation of the Self-Stigma Questionnaire (SSQ) for people with schizophrenia and its relation to social functioning,” Comprehensive Psychiatry, 2015. View at Publisher · View at Google Scholar
  • Christophe E. de Bézenac, Vanessa Sluming, Noreen O’Sullivan, and Rhiannon Corcoran, “Ambiguity between self and other: Individual differences in action attribution,” Consciousness and Cognition, vol. 35, pp. 1–15, 2015. View at Publisher · View at Google Scholar
  • Katherine L. Narr, and Amber M. Leaver, “Connectome and schizophrenia,” Current Opinion in Psychiatry, vol. 28, no. 3, pp. 229–235, 2015. View at Publisher · View at Google Scholar
  • Shirlene Pang, Mythily Subramaniam, Edimansyah Abdin, Lye Yin Poon, Siow Ann Chong, and Swapna Verma, “Gender differences in patients with first-episode psychosis in the Singapore Early Psychosis Intervention Programme,” Early Intervention in Psychiatry, 2015. View at Publisher · View at Google Scholar
  • Foteini Tseliou, Sonia Johnson, Barnaby Major, Nikola Rahaman, John Joyce, Jo Lawrence, Farhana Mann, Andrew Tapfumaneyi, Brock Chisholm, Nick Chamberlain-Kent, Mark F. Hinton, and Helen L. Fisher, “Gender differences in one-year outcomes of first-presentation psychosis patients in inner-city UK Early Intervention Services,” Early Intervention in Psychiatry, 2015. View at Publisher · View at Google Scholar
  • Cenk Tek, Suat Kucukgoncu, Sinan Guloksuz, Scott W. Woods, Vinod H. Srihari, and Aniyizhai Annamalai, “Antipsychotic-induced weight gain in first-episode psychosis patients: a meta-analysis of differential effects of antipsychotic medications,” Early Intervention in Psychiatry, 2015. View at Publisher · View at Google Scholar
  • Ruth A. Lanius, Paul A. Frewen, Mischa Tursich, Rakesh Jetly, and Margaret C. McKinnon, “Restoring large-scale brain networks in PTSD and related disorders: a proposal for neuroscientifically-informed treatment interventions,” European Journal of Psychotraumatology, vol. 6, no. 0, 2015. View at Publisher · View at Google Scholar
  • Leticia S. Czepielewski, Raffael Massuda, Pedro Goi, Mireia Sulzbach-Vianna, Ramiro Reckziegel, Monise Costanzi, Flavio Kapczinski, Adriane R. Rosa, and Clarissa S. Gama, “Verbal episodic memory along the course of schizophrenia and bipolar disorder: A new perspective,” European Neuropsychopharmacology, vol. 25, no. 2, pp. 169–175, 2015. View at Publisher · View at Google Scholar
  • Tseng Ping-Tao, Cheng Yu-Shian, Chen Yen-Wen, Wu Ching-Kuan, and Lin Pao-Yen, “Increased levels of vascular endothelial growth factor in patients with major depressive disorder: A meta-analysis,” European Neuropsychopharmacology, 2015. View at Publisher · View at Google Scholar
  • S. Ittig, E. Studerus, M. Papmeyer, M. Uttinger, S. Koranyi, A. Ramyead, and A. Riecher-Roessler, “Sex differences in cognitive functioning in at-risk mental state for psychosis, first episode psychosis and healthy control subjects,” European Psychiatry, vol. 30, no. 2, 2015. View at Publisher · View at Google Scholar
  • B. Chiliza, L. Asmal, P. Oosthuizen, E. Van Niekerk, R. Erasmus, M. Kidd, A. Malhotra, and R. Emsley, “Changes in body mass and metabolic profiles in patients with first-episode schizophrenia treated for 12 months with a first-generation antipsychotic,” European Psychiatry, vol. 30, no. 2, 2015. View at Publisher · View at Google Scholar
  • Mikael Mokkonen, and Bernard J. Crespi, “Genomic conflicts and sexual antagonism in human health: insights from oxytocin and testosterone,” Evolutionary Applications, 2015. View at Publisher · View at Google Scholar
  • Jan Malte Bumb, Frank Enning, and F Markus Leweke, “Drug repurposing and emerging adjunctive treatments for schizophrenia,” Expert Opinion on Pharmacotherapy, pp. 1–19, 2015. View at Publisher · View at Google Scholar
  • Adrianna Mendrek, “Is It Important to Consider Sex and Gender in Neurocognitive Studies?,” Frontiers in Psychiatry, vol. 6, 2015. View at Publisher · View at Google Scholar
  • Michele Ribolsi, Jasper Feyaerts, and Stijn Vanheule, “Metaphor in psychosis: on the possible convergence of Lacanian theory and neuro-scientific research,” Frontiers In Psychology, vol. 6, 2015. View at Publisher · View at Google Scholar
  • Steffen Moritz, Teresa Thoering, Simone Kühn, Bastian Willenborg, Stefan Westermann, and Matthias Nagel, “Metacognition-augmented cognitive remediation training reduces jumping to conclusions and overconfidence but not neurocognitive deficits in psychosis,” Frontiers in Psychology, vol. 6, 2015. View at Publisher · View at Google Scholar
  • Anja Vaskinn, Bjørnar T. Antonsen, Ragnhild A. Fretland, Isabel Dziobek, Kjetil Sundet, and Theresa Wilberg, “Theory of mind in women with borderline personality disorder or schizophrenia: differences in overall ability and error patterns,” Frontiers in Psychology, vol. 6, 2015. View at Publisher · View at Google Scholar
  • Diana Rofail, Catherine Acquadro, Cecile Izquierdo, Antoine Regnault, and Steven H. Zarit, “Cross-cultural adaptation of the Schizophrenia Caregiver Questionnaire (SCQ) and the Caregiver Global Impression (CaGI) Scales in 11 languages,” Health And Quality Of Life Outcomes, vol. 13, 2015. View at Publisher · View at Google Scholar
  • J. Zhang, L. Ye, W. Wang, G. Du, X. Yu, X. Zhu, Q. Dong, X. Cen, X. Guan, F. Fu, and J. Tian, “A 12-week subchronic intramuscular toxicity study of risperidone-loaded microspheres in rats,” Human & Experimental Toxicology, vol. 34, no. 2, pp. 205–223, 2015. View at Publisher · View at Google Scholar
  • Lucia Margari, Emilia Matera, Maria G. Petruzzelli, Marta Simone, Anna L. Lamanna, Adriana Pastore, Vincenzo O. Palmieri, and Francesco Margari, “Prolactin variations during risperidone therapy in a sample of drug-naive children and adolescents,” International Clinical Psychopharmacology, vol. 30, no. 2, pp. 103–108, 2015. View at Publisher · View at Google Scholar
  • Sai Krishna Tikka, S. Haque Nizamie, Nishant Goyal, N. Pradhan, Deyashini Lahiri Tikka, and Mohammad Zia Ul Haq Katshud, “Evaluation of spontaneous dense array gamma oscillatory activity and minor physical anomalies as a composite neurodevelopmental endophenotype in schiz,” International Journal Of Developmental Neuroscience, vol. 40, pp. 43–51, 2015. View at Publisher · View at Google Scholar
  • Greet Wilrycx, Marcel Croon, Anneloes Van den Broek, and Chijs van Nieuwenhuizen, “Evaluation of a recovery-oriented care training program for mental healthcare professionals: Effects on mental health consumer outcomes,” International Journal Of Social Psychiatry, vol. 61, no. 2, pp. 164–173, 2015. View at Publisher · View at Google Scholar
  • Steffen Moritz, Anja S. Göritz, Jürgen Gallinat, Milena Schafschetzy, Niels Van Quaquebeke, Maarten J.V. Peters, and Christina Andreou, “Subjective competence breeds overconfidence in errors in psychosis. A hubris account of paranoia,” Journal of Behavior Therapy and Experimental Psychiatry, 2015. View at Publisher · View at Google Scholar
  • Alexandre González-Rodríguez, Oriol Molina-Andreu, Rafael Penadés, Miquel Bernardo, and Rosa Catalán, “Therapeutic Approach to Delusional Disorder Based on Psychopathological Complexity,” Journal of Clinical Psychopharmacology, vol. 35, no. 2, pp. 201–202, 2015. View at Publisher · View at Google Scholar
  • Shahrzad Mazhari, Yousef Moghadas Tabrizi, and Alireza Ghaffari Nejad, “Neural Evidence for Compromised Mental Imagery in Individuals With Chronic Schizophrenia,” Journal Of Neuropsychiatry And Clinical Neurosciences, vol. 27, no. 2, pp. 127–132, 2015. View at Publisher · View at Google Scholar
  • Yun Xiu, Xiang-ru Kong, Lei Zhang, Xuan Qiu, Yuan Gao, Chun-xia Huang, Feng-lei Chao, San-rong Wang, and Yong Tang, “The myelinated fiber loss in the corpus callosum of mouse model of schizophrenia induced by MK-801,” Journal of Psychiatric Research, 2015. View at Publisher · View at Google Scholar
  • William P. Horan, Steven P. Reise, Robert S. Kern, Junghee Lee, David L. Penn, and Michael F. Green, “Structure and Correlates of Self-Reported Empathy in Schizophrenia,” Journal of Psychiatric Research, 2015. View at Publisher · View at Google Scholar
  • Gwenole Loas, Masanari Itokawa, Youssef Kouidrat, Ali Amad, Makoto Arai, Mitsuhiro Miyashita, and Jean-Daniel Lalau, “Advanced glycation end products and schizophrenia: A systematic review,” Journal of Psychiatric Research, 2015. View at Publisher · View at Google Scholar
  • Carolyn Helene Baldwin, and Lalit K. Srivastava, “Can the neurodevelopmental theory account for sex differences in schizophrenia across the life span?,” Journal Of Psychiatry & Neuroscience, vol. 40, no. 2, pp. 75–77, 2015. View at Publisher · View at Google Scholar
  • Meng-Juan Jing, Jia-Ji Wang, Wei-Quan Lin, Yi-Xiong Lei, and Pei-Xi Wang, “A Community-Based Cross-sectional Study of Fatigue in Middle-aged and Elderly Women,” Journal of Psychosomatic Research, 2015. View at Publisher · View at Google Scholar
  • Nuran Karabulut, Serkan Bilgiç, Mehmet Gürkan Gürok, and Fatih Karaboğa, “Is there any role of latent toxoplasmosis in schizophrenia disease?,” Journal of the Chinese Medical Association, 2015. View at Publisher · View at Google Scholar
  • Rui Lopes, Raquel Soares, Rui Coelho, and Margarida Figueiredo-Braga, “Angiogenesis in the pathophysiology of Schizophrenia – a comprehensive review and a conceptual hypothesis,” Life Sciences, 2015. View at Publisher · View at Google Scholar
  • Ahmed Saad, Doaa A. Khalifa, Marwa El-Missiry, Amira El-Batrawy, and Sameh Taha, “Sexual dysfunction related to typical and atypical antipsychotics in drug naive psychotic patients,” Middle East Current Psychiatry, vol. 22, no. 2, pp. 76–82, 2015. View at Publisher · View at Google Scholar
  • T Lencz, and A K Malhotra, “Targeting the schizophrenia genome: a fast track strategy from GWAS to clinic,” Molecular Psychiatry, 2015. View at Publisher · View at Google Scholar
  • A Pillai, K R Howell, A O Ahmed, D Weinberg, K M Allen, J Bruggemann, R Lenroot, D Liu, C Galletly, C S Weickert, and T W Weickert, “Association of serum VEGF levels with prefrontal cortex volume in schizophrenia,” Molecular Psychiatry, 2015. View at Publisher · View at Google Scholar
  • Gen Yan, Yinghua Xuan, Zhuozhi Dai, Zhiwei Shen, Guishan Zhang, Haiyun Xu, and Renhua Wu, “Brain Metabolite Changes in Subcortical Regions After Exposure to Cuprizone for 6 Weeks: Potential Implications for Schizophrenia,” Neurochemical Research, vol. 40, no. 1, pp. 49–58, 2015. View at Publisher · View at Google Scholar
  • TianMei Si, QingRong Tan, KeRang Zhang, Yang Wang, and Qing Rui, “An open-label, flexible-dose study of paliperidone extended-release in Chinese patients with first-onset psychosis,” Neuropsychiatric Disease And Treatment, vol. 11, pp. 87–95, 2015. View at Publisher · View at Google Scholar
  • Ping Yang, Zhenyong Gao, Handi Zhang, Zeman Fang, Cairu Wu, Haiyun Xu, and Qing-Jun Huang, “Changes in proinflammatory cytokines and white matter in chronically stressed rats,” Neuropsychiatric Disease And Treatment, vol. 11, pp. 597–607, 2015. View at Publisher · View at Google Scholar
  • Hiroyo Kuwabara, Yoshimichi Saito, and Joerg Mahlich, “Adherence and rehospitalizations in patients with schizophrenia: evidence from Japanese claims data,” Neuropsychiatric Disease And Treatment, vol. 11, pp. 935–940, 2015. View at Publisher · View at Google Scholar
  • Caroline Cellard, Clare Reeder, Andrée-Anne Paradis-Giroux, Marc-André Roy, Elsa Gilbert, Hans Ivers, Roch-Hugo Bouchard, Michel Maziade, and Til Wykes, “A feasibility study of a new computerised cognitive remediation for young adults with schizophrenia,” Neuropsychological Rehabilitation, pp. 1–24, 2015. View at Publisher · View at Google Scholar
  • Alfredo Ramos-Miguel, William G. Honer, Heidi N. Boyda, Ken Sawada, Clare L. Beasley, Ric M. Procyshyn, and Alasdair M. Barr, “Exercise prevents downregulation of hippocampal presynaptic proteins following olanzapine-elicited metabolic dysregulation in rats: distinct roles of inhibitory and excitatory terminals,” Neuroscience, 2015. View at Publisher · View at Google Scholar
  • Kirran Bakhshi, and Steven A. Chance, “The Neuropathology of schizophrenia: a selective review of past studies and emerging themes in brain structure and cytoarchitecture,” Neuroscience, 2015. View at Publisher · View at Google Scholar
  • Jana Trebatická, and Zdeňka Ďuračková, “Psychiatric Disorders and Polyphenols: Can They Be Helpful in Therapy?,” Oxidative Medicine and Cellular Longevity, vol. 2015, pp. 1–16, 2015. View at Publisher · View at Google Scholar
  • Colin Martin, Matthew Witt, Kathryn Puskar, Cynthia Slivka, and Heeyoung Lee, “A Case Study on Promoting Neuroplasticity in a Patient With Schizophrenia,” Perspectives in Psychiatric Care, 2015. View at Publisher · View at Google Scholar
  • Choochart Wong-Anuchit, “Clinical Management of Antipsychotic-Induced Hyperprolactinemia,” Perspectives in Psychiatric Care, 2015. View at Publisher · View at Google Scholar
  • Kudrat Randhawa, Deepak Kumar, Anupam Jamwal, and Suresh Kumar, “ Screening of antidepressant activity and estimation of quercetin from Coccinia indica using TLC densitometry ,” Pharmaceutical Biology, pp. 1–8, 2015. View at Publisher · View at Google Scholar
  • Sanja Kilian, Laila Asmal, Anneke Goosen, Bonginkosi Chiliza, Lebogang Phahladira, and Robin Emsley, “Instruments Measuring Blunted Affect in Schizophrenia: A Systematic Review,” Plos One, vol. 10, no. 6, 2015. View at Publisher · View at Google Scholar
  • Meng-Lin Li, Xi-Quan Hu, Feng Li, and Wen-Jun Gao, “Perspectives on the mGluR2/3 agonists as a therapeutic target for schizophrenia: Still promising or a dead end?,” Progress In Neuro-Psychopharmacology & Biological Psychiatry, vol. 60, pp. 66–76, 2015. View at Publisher · View at Google Scholar
  • Lorenz Deutschenbaur, Johannes Beck, Anna Kiyhankhadiv, Markus Mühlhauser, Stefan Borgwardt, Marc Walter, Gregor Hasler, Daniel Sollberger, and Undine E. Lang, “Role of Calcium, Glutamate and NMDA in major depression and therapeutic application,” Progress in Neuro-Psychopharmacology and Biological Psychiatry, 2015. View at Publisher · View at Google Scholar
  • Julian A. Jaros, Hassan Rahmoune, Hendrik Wesseling, F. Markus Leweke, Sureyya Ozcan, Paul C. Guest, and Sabine Bahn, “Effects of olanzapine on serum protein phosphorylation patterns in patients with schizophrenia,” PROTEOMICS - Clinical Applications, 2015. View at Publisher · View at Google Scholar
  • Aurigena Antunes de Araújo, Susana Barbosa Ribeiro, Ana Cely Souza dos Santos, Telma Maria Araújo Moura Lemos, Caroline Addison Xavier Medeiros, Gerlane Coelho Bernardo Guerra, Raimundo Fernandes de Araújo Júnior, Antoni Serrano-Blanco, and Maria Rubio-Valera, “Quality of Life and Hormonal, Biochemical, and Anthropometric Profile Between Olanzapine and Risperidone Users,” Psychiatric Quarterly, 2015. View at Publisher · View at Google Scholar
  • Hsue-Wei Chan, Chin-Yu Huang, Wen-Jui Feng, and Yung-Chieh Yen, “Risperidone long-acting injection and 1-year rehospitalization rate of schizophrenia patients: A retrospective cohort study,” Psychiatry and Clinical Neurosciences, 2015. View at Publisher · View at Google Scholar
  • Stavroula I. Bargiota, Konstantinos Bonotis, Ioannis E. Messinis, Georgios Garyfallos, and Nikiforos V. Angelopoulos, “Hyperprolactinaemia: Psychological aspects and menstrual attitudes of women with schizophrenia,” Psychiatry Research, 2015. View at Publisher · View at Google Scholar
  • Cristiana Montemagni, Tiziana Frieri, Arianna Blandamura, Vincenzo Villari, and Paola Rocca, “Gender differences in 353 inpatients with acute psychosis: The experience of one Psychiatric Emergency Service of Turin,” Psychiatry Research, 2015. View at Publisher · View at Google Scholar
  • Bun-Hee Lee, Jin-Pyo Hong, Jung-A Hwang, Byung-Joo Ham, Kyoung-Sae Na, Won-Joong Kim, Jose Trigo, and Yong-Ku Kim, “Alterations in plasma vascular endothelial growth factor levels in patients with schizophrenia before and after treatment,” Psychiatry Research, 2015. View at Publisher · View at Google Scholar
  • Alejandra Caqueo-Urízar, Laurent Boyer, Karine Baumstarck, and Stephen E. Gilman, “The relationships between patients’ and caregivers’ beliefs about the causes of schizophrenia and clinical outcomes in Latin American countries,” Psychiatry Research, 2015. View at Publisher · View at Google Scholar
  • Tal Sela, Michal Lavidor, and Rachel L.C. Mitchell, “A possible contributory mechanism for impaired idiom perception in schizophrenia,” Psychiatry Research, 2015. View at Publisher · View at Google Scholar
  • Igor Nenadic, Kerstin Langbein, Maren Dietzek, Anne Forberg, Stefan Smesny, and Heinrich Sauer, “Cognitive function in euthymic bipolar disorder (BP I) patients with a history of psychotic symptoms vs. schizophrenia,” Psychiatry Research, pp. PSYD1500176, 2015. View at Publisher · View at Google Scholar
  • Marta Canuti, Nico JM van Beveren, Seyed Mohammad Jazaeri Farsani, Michel de Vries, Martin Deijs, Maarten F Jebbink, Hans L Zaaijer, Barbera DC van Schaik, Antoine HC van Kampen, Antoinette C van der Kuyl, Lieuwe de Haan, Jitschak G Storosum, and Lia van der Hoek, “Viral metagenomics in drug-naïve, first-onset schizophrenia patients with prominent negative symptoms,” Psychiatry Research, pp. PSYD1400873, 2015. View at Publisher · View at Google Scholar
  • David L. Perez, Hong Pan, Daniel S. Weisholtz, James C. Root, Oliver Tuescher, David B. Fischer, Tracy Butler, David R. Vago, Nancy Isenberg, Jane Epstein, Yulia Landa, Thomas E. Smith, Adam J. Savitz, David A. Silbersweig, and Emily Stern, “Altered threat and safety neural processing linked to persecutory delusions in schizophrenia: a two-task fMRI study,” Psychiatry Research: Neuroimaging, 2015. View at Publisher · View at Google Scholar
  • Barbara Remberk, Anna Katarzyna Bazynska, Zofia Bronowska, Pawel Potocki, Anna Krempa-Kowalewska, Piotr Niwinski, and Filip Rybakowski, “Which Aspects of Long-Term Outcome Are Predicted by Positive and Negative Symptoms in Early-Onset Psychosis? An Exploratory Eight-Year Follow-Up Study,” Psychopathology, vol. 48, no. 1, pp. 47–55, 2015. View at Publisher · View at Google Scholar
  • Daniel Nischk, Christina Doelker, Johannes Rusch, and Philippe Merz, “From Theory to Clinical Practice: A Phenomenologically Inspired Intervention for Patients with Schizophrenia,” Psychopathology, vol. 48, no. 2, pp. 127–136, 2015. View at Publisher · View at Google Scholar
  • Joanna M. Wieronska, Anna Slawinska, Magdalena Lason-Tyburkiewicz, Piotr Gruca, Mariusz Papp, Stevin H. Zorn, Dario Doller, Natalia Kleczek, Karolina Noworyta-Sokolowska, Krystyna Golembiowska, and Andrzej Pilc, “The antipsychotic-like effects in rodents of the positive allosteric modulator Lu AF21934 involve 5-HT1A receptor signaling: mechanistic studies,” Psychopharmacology, vol. 232, no. 1, pp. 259–273, 2015. View at Publisher · View at Google Scholar
  • Martina Fieker, and Brooke C. Schneider, “Metakognitives Training bei Schizophrenie,” Psychotherapeut, 2015. View at Publisher · View at Google Scholar
  • Gabrielle Alexander, Charlotte-Ellen Bebee, Kelly-Maria Chen, Ross-Michael Des Vignes, Brandon Dixon, Richard Escoffery, Chazine Francis, DeAngelo Francis, Zahra Mendoza, Skyla Montano, Maxine Nelson, Stephon Ramcharan, Siobhan Richards, and Maria D. Jackson, “Burden of caregivers of adult patients with schizophrenia in a predominantly African ancestry population,” Quality of Life Research, 2015. View at Publisher · View at Google Scholar
  • Johanna C. Badcock, “A Neuropsychological Approach to Auditory Verbal Hallucinations and Thought Insertion - Grounded in Normal Voice Perception,” Review of Philosophy and Psychology, 2015. View at Publisher · View at Google Scholar
  • M. Aurora Falcone, Robin M. Murray, Benjamin D. R. Wiffen, Jennifer A. O'Connor, Manuela Russo, Anna Kolliakou, Simona Stilo, Heather Taylor, Poonam Gardner-Sood, Alessandra Paparelli, Fatima Jichi, Marta Di Forti, Anthony S. David, Daniel Freeman, and Suzanne Jolley, “Jumping to Conclusions, Neuropsychological Functioning, and Delusional Beliefs in First Episode Psychosis,” Schizophrenia Bulletin, vol. 41, no. 2, pp. 411–418, 2015. View at Publisher · View at Google Scholar
  • Ulrich Ettinger, Christine Mohr, Diane C. Gooding, Alex S. Cohen, Alexander Rapp, Corinna Haenschel, and Sohee Park, “Cognition and Brain Function in Schizotypy: A Selective Review,” Schizophrenia Bulletin, vol. 41, pp. S417–S426, 2015. View at Publisher · View at Google Scholar
  • K. Q. Do, M. Cuenod, and T. K. Hensch, “Targeting Oxidative Stress and Aberrant Critical Period Plasticity in the Developmental Trajectory to Schizophrenia,” Schizophrenia Bulletin, 2015. View at Publisher · View at Google Scholar
  • Souhel Najjar, and Daniel M. Pearlman, “Neuroinflammation and white matter pathology in schizophrenia: systematic review,” Schizophrenia Research, vol. 161, no. 1, pp. 102–112, 2015. View at Publisher · View at Google Scholar
  • Ofer Pasternak, Carl-Fredrik Westin, Brian Dahlben, Sylvain Bouix, and Marek Kubicki, “The extent of diffusion MRI markers of neuroinflammation and white matter deterioration in chronic schizophrenia,” Schizophrenia Research, vol. 161, no. 1, pp. 113–118, 2015. View at Publisher · View at Google Scholar
  • Kazuteru Egashira, Koji Matsuo, Mami Nakashima, Toshio Watanuki, Kenichiro Harada, Masayuki Nakano, Toshio Matsubara, Kanji Takahashi, and Yoshifumi Watanabe, “Blunted brain activation in patients with schizophrenia in response to emotional cognitive inhibition: A functional near-infrared spectroscopy study,” Schizophrenia Research, 2015. View at Publisher · View at Google Scholar
  • Robert A. Renes, Anouk van der Weiden, Merel Prikken, René S. Kahn, Henk Aarts, and Neeltje E.M. van Haren, “Abnormalities in the experience of self-agency in schizophrenia: A replication study,” Schizophrenia Research, 2015. View at Publisher · View at Google Scholar
  • Marianna Giannitelli, Jean Xavier, Anne François, Nicolas Bodeau, Claudine Laurent, David Cohen, and Laurence Chaby, “Facial, vocal and cross-modal emotion processing in early-onset schizophrenia spectrum disorders,” Schizophrenia Research, 2015. View at Publisher · View at Google Scholar
  • George C. Nitzburg, Katherine E. Burdick, Anil K. Malhotra, and Pamela DeRosse, “Social cognition in patients with schizophrenia spectrum and bipolar disorders with and without psychotic features,” Schizophrenia Research: Cognition, 2015. View at Publisher · View at Google Scholar
  • Joshua T Kantrowitz, Scott W Woods, Eva Petkova, Barbara Cornblatt, Cheryl M Corcoran, Huaihou Chen, Gail Silipo, and Daniel C Javitt, “D-serine for the treatment of negative symptoms in individuals at clinical high risk of schizophrenia: a pilot, double-blind, placebo-controlled, randomised parallel group mechanistic proof-of-concept trial,” The Lancet Psychiatry, vol. 2, no. 5, pp. 403–412, 2015. View at Publisher · View at Google Scholar
  • Ana Barajas, Susana Ochoa, Jordi E. Obiols, and Lluís Lalucat-Jo, “Gender Differences in Individuals at High-Risk of Psychosis: A Comprehensive Literature Review,” The Scientific World Journal, vol. 2015, pp. 1–13, 2015. View at Publisher · View at Google Scholar
  • Louise B. Glenthoj, Birgitte Fagerlund, Lasse Randers, Carsten R. Hjorthoj, Christina Wenneberg, Kristine Krakauer, Astrid Vosgerau, Christian Gluud, Alice Medalia, David L. Roberts, and Merete Nordentoft, “The FOCUS trial: cognitive remediation plus standard treatment versus standard treatment for patients at ultra-high risk for psychosis: study protocol,” Trials, vol. 16, 2015. View at Publisher · View at Google Scholar